Article thumbnail

The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations

By Tuula K Outinen, Satu M Mäkelä, Ilpo O Ala-Houhala, Heini SA Huhtala, Mikko Hurme, Antti S Paakkala, Ilkka H Pörsti, Jaana T Syrjänen and Jukka T Mustonen
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2885391
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2002). A: Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism.
  2. (1996). A: Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol
  3. (2004). Canas-Coto A, Yan SB: Systemic host inflammatory and coagulation response in the Dengue virus primo-infection. Cytokine
  4. (1989). Ciliberto G: Dual control of Creactive protein gene expression by interleukin-1 and interleukin-6. Embo J
  5. (1981). Circulating immune complexes, immunoconglutinins, and rheumatoid factors in nephropathia epidemica.
  6. (1983). Dalrymple JM: Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology
  7. (2007). Du Clos TW: C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors.
  8. (2006). Du Clos TW: Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. Arthritis Rheum
  9. (2005). Du Clos TW: Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein. Arthritis Rheum
  10. (1999). FA: High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis
  11. (2001). FG: Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses.
  12. (1996). Holthöfer H: Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol
  13. (2004). Ikizler TA: Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int
  14. (1993). Lankinen H: Susceptibility of human cells to Puumala virus infection.
  15. (1998). Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.
  16. (2002). Lundkvist Å: Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques.
  17. (2007). Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in the respiratory tracts of human infants following paramyxovirus infection. J Med Virol
  18. (1991). Mechanisms of disease in Hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev Infect Dis
  19. (2004). Medical imaging in nephropathia epidemica and their clinical correlations.
  20. (1971). Nephropathia epidemica in Finland. A clinical histological and epidemiological study. Ann Clin Res
  21. (1980). Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.
  22. (2007). PA: Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis
  23. (2004). Pasternack A: Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis.
  24. (2004). Proinflammatory cytokines and chemokines in humans with Japanese encephalitis.
  25. (2000). Repo H: Systemic inflammation in hemorrhagic fever with renal syndrome correlates with hypotension and thrombocytopenia but not with renal injury.
  26. (2010). Tärnvik A: Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, Received:
  27. (1992). Tärnvik A: Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection
  28. (1996). Vaheri A: Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells.
  29. (1999). Vaheri A: Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis
  30. (1996). Vaheri A: Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int
  31. (2003). Vaheri A: Hantavirus infections in Europe. Lancet Infect Dis
  32. (1994). Vaheri A: Nephropathia epidemica in Finland: a retrospective study of 126 cases.
  33. (1998). Vaheri A: Pathogenesis of Puumala and other hantavirus infections. Rev Med Virol
  34. (2004). Vyse TJ: Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet
  35. (2006). Yeh TM: Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg
  36. (2007). Yilmaz ME: The evaluation of effects of demographic features, biochemical parameters, and cytokines on clinical outcomes in patients with acute renal failure. Ren Fail